Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System

BACKGROUND: New drugs are needed to treat visceral leishmaniasis (VL) because the current therapies are toxic, expensive, and parasite resistance may weaken drug efficacy. We established a novel ex vivo splenic explant culture system from hamsters infected with luciferase-transfected Leishmania dono...

Descripción completa

Detalles Bibliográficos
Autores principales: Osorio, Yaneth, Travi, Bruno L., Renslo, Adam R., Peniche, Alex G., Melby, Peter C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039689/
https://www.ncbi.nlm.nih.gov/pubmed/21358812
http://dx.doi.org/10.1371/journal.pntd.0000962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039689/
https://www.ncbi.nlm.nih.gov/pubmed/21358812
http://dx.doi.org/10.1371/journal.pntd.0000962

Ejemplares similares